Considering the voluntary U.S. FDA pilot program that uses Capability Maturity Model Integration (CMMI) Before you sign up, read this article. You’ll learn what quality, compliance and regulatory officials at the three large device firms (including Baxter) have to say about the value of the program. They explain the benefits of participation and share their approaches. The article also walks readers through of the CMMI appraisal process. (Hint:It’s nothing like a typical regulatory audit.) Finally, it also explores how Baxter created its own maturity model. This is the third in a Medtech Insight series on the appraisal of manufacturing capability and maturity.
This product is an industry newsletter. Each license type allows a set number of users to access the newsletter for the length of the subscription period. This product is an industry newsletter. This is a single user license, allowing one user access to the product. The product is a PDF. This product is an industry newsletter. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
*Required Information
This website uses cookies to ensure you get the best experience. Learn more